Abstract:Excitability is a fundamental characteristic of cardiac cells, which is delicately determined by ion channel activities modulated by many factors. MicroRNA (miRNA) expression is dynamically regulated and altered miRNA expression can render expression deregulation of ion channel genes leading to channelopathies-arrhythmogenesis. Indeed, evidence has emerged indicating the crucial role of miRNAs in controlling cardiac excitability by regulating expression of ion channel genes at the post-transcriptional level. However, the very limited experimental data in the literature hinder our understanding of the role of miRNAs and the often one-to-one interaction between miRNA and ion-channel gene in the published studies also casts a doubt about fullness of our view. Unfortunately, currently available techniques do not permit thorough characterization of miRNA targeting; computational prediction programs remain the only source for rapid identification of a putative miRNA target in silico. We conducted a rationally designed bioinformatics analysis in conjunction with experimental approaches to identify the miRNAs from the currently available miRNA databases which have the potential to regulate human cardiac ion channel genes and to validate the analysis with several pathological settings associated with the deregulated miRNAs and ion channel genes in the heart. We established a matrix of miRNAs that are expressed in cardiac cells and have the potential to regulate the genes encoding cardiac ion channels and transporters. We were able to explain a particular ionic remodeling process in hypertrophy/heart failure, myocardial ischemia, or atrial fibrillation with the corresponding deregulated miRNAs under that pathological condition; the changes of miRNAs appear to have anti-correlation with the changes of many of the genes encoding cardiac ion channels under these situations. These results indicate that multiple miRNAs might be critically involved in the electrical/ionic remodeling processes of cardiac diseases through altering their expression in cardiac cells, which has not been uncovered by previous experimental studies.

Down-regulation of miR-1/miR-133 Contributes to Re-expression of Pacemaker Channel Genes HCN2 and HCN4 in Hypertrophic Heart,

Abstract 836: Downregulation of Microrna-1/Microrna-133 and Overexpression of Sp1 Activates Re-expression of Pacemaker Channel Genes HCN2 and HCN4 in Hypertrophic Heart

Cardiac Hypertrophy and Dysfunction Induced by Overexpression of Mir-214 in Vivo

Transcriptional Control Of Pacemaker Channel Genes Hcn2 And Hcn4 By Sp1 And Implications In Re-Expression Of These Genes In Hypertrophied Myocytes

Inhibition of TRPC1 Prevents Cardiac Hypertrophy Via NF-κB Signaling Pathway in Human Pluripotent Stem Cell-Derived Cardiomyocytes.

Microrna-340-5p Functions Downstream Of Cardiotrophin-1 To Regulate Cardiac Eccentric Hypertrophy And Heart Failure Via Target Gene Dystrophin

MicroRNA-133a Protects Against Myocardial Fibrosis and Modulates Electrical Repolarization Without Affecting Hypertrophy in Pressure-Overloaded Adult Hearts.

MiR-27a-3p/Hoxa10 Axis Regulates Angiotensin II-Induced Cardiomyocyte Hypertrophy by Targeting Kv4.3 Expression

Attenuation of Microrna-1 Derepresses the Cytoskeleton Regulatory Protein Twinfilin-1 to Provoke Cardiac Hypertrophy

Mir-139-5p Inhibits Isoproterenol-Induced Cardiac Hypertrophy by Targetting C-Jun

MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress.

CDK6 Mediates the Effect of Attenuation of Mir-1 on Provoking Cardiomyocyte Hypertrophy

Microrna-1 Negatively Regulates Expression of the Hypertrophy-Associated Calmodulin and Mef2a Genes

Regulation of human cardiac ion channel genes by microRNAs: theoretical perspective and pathophysiological implications

Cardiac Hypertrophy Is Positively Regulated by MicroRNA miR-23a

Micrornas Are Dynamically Regulated in Hypertrophic Hearts, and Mir-199a is Essential for the Maintenance of Cell Size in Cardiomyocytes

miR-212 Promotes Cardiomyocyte Hypertrophy through Regulating Transcription Factor 7 Like 2

miR-208a in Cardiac Hypertrophy and Remodeling

E0164 Dysregulation of Mir-1 after Left Ventricular Hypertrophy Reveals a Role of Mir-1 in Ventricular Arrhythmia Occurred in the Hypertensive Heart

Loss of MicroRNA-155 protects the heart from pathological cardiac hypertrophy.

Reciprocal Repression Between MicroRNA-133 and Calcineurin Regulates Cardiac Hypertrophy